Grith Hagel
Founder at 2CUREX AB
Profile
Grith Hagel is the founder of 2cureX ApS, where she holds the title of Head-Project Management since 2011.
She is also the founder of 2cureX AB, where she holds the title of Vice President-Innovation.
Ms. Hagel is also the founder of Noapab Holdings A..
Ms. Hagel's former jobs include being a Principal at Novo Nordisk A and Carlsberg A.
Grith Hagel active positions
| Companies | Position | Start |
|---|---|---|
| 2CUREX AB | Founder | 2005-12-31 |
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Founder | 2010-04-06 |
Former positions of Grith Hagel
| Companies | Position | End |
|---|---|---|
| CARLSBERG A/S | Corporate Officer/Principal | - |
| Noapab Holdings A/S | Founder | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| CARLSBERG A/S | Consumer Non-Durables |
| 2CUREX AB | Health Technology |
| Private companies | 2 |
|---|---|
| Noapab Holdings A/S | Commercial Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |
- Stock Market
- Insiders
- Grith Hagel